Siemens Healthineers, with over 125 years of experience, is a leading global medical technology company dedicated to pioneering breakthroughs in healthcare. Their comprehensive portfolio encompasses medical imaging, laboratory diagnostics, point-of-care testing, and advanced therapies, including image-guided therapy and cancer care solutions. Emphasizing innovation and sustainability, Siemens Healthineers integrates artificial intelligence and digital health solutions to enhance patient outcomes and optimize clinical workflows. With a presence in over 70 countries, they serve healthcare providers worldwide, addressing challenges across various medical disciplines.
Siemens Healthineers introduces an integrated workflow that connects coronary CT analysis with catheter lab guidance for percutaneous coronary intervention planning and execution.
Siemens Healthineers has introduced CE-marked AI-driven contour automation for radiotherapy planning, targeting workflow standardization in oncology imaging and treatment design.
Siemens Healthineers expands its diagnostics portfolio with automated assays to quantify tau biomarkers, supporting scalable brain health research and clinical evidence generation.
Siemens Healthineers integrates artificial intelligence into angiography platforms to automate motion correction and vascular mapping for targeted embolization procedures in the automotive data ecosystem.
The strategic partnership integrates AI-enabled MRI protocols and digital twin technology to enhance care for neurodegenerative diseases, prostate cancer, and metastatic liver tumors.
Rising demand for precision in image-guided therapy drives adoption of AI-based live denoising, delivering clearer images at the same dose. Optiq AI debuts across three new platforms.
The 100 cm flared bore enhances access and ergonomics, using advanced imaging and radiation-free guidance for confident planning and precise targeting during minimally invasive procedures.